MCM
TDOC icon

Moore Capital Management’s Teladoc Health TDOC Stock Holding History

Moore Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Sell
27,503
-379,128
-93% -$2.52M ﹤0.01% 560
2026
Q1 		$2.22M Buy
406,631
+158,110
+64% +$887K 0.05% 267
2025
Q4 		$1.74M Buy
+248,521
New +$1.95M 0.03% 398
2025
Q3 		– Sell
-154,282
Closed -$1.34M – 735
2025
Q2 		$1.34M Buy
154,282
+54,262
+54% +$393K 0.02% 353
2025
Q1 		$796K Sell
100,020
-78,441
-44% -$794K 0.02% 331
2024
Q4 		$1.62M Buy
+178,461
New +$1.72M 0.02% 340

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Moore Capital Management's TDOC Position: Q2 2026 in Review

Moore Capital Management reduced its Teladoc Health (TDOC) stake by 93% in Q2 2026, selling an estimated $2.52M and leaving 27,503 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #560.

Moore Capital Management first reported a position in TDOC in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.22M in Q1 2026. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Moore Capital Management held 27,503 shares of Teladoc Health worth $233K as of Q2 2026.
  • Moore Capital Management sold 379,128 Teladoc Health shares in Q2 2026, an estimated $2.52M.
  • Teladoc Health made up ﹤0.01% of Moore Capital Management's portfolio in Q2 2026, its #560 holding.
  • Moore Capital Management first reported a position in Teladoc Health in Q4 2024 and has held it in 6 quarters since.
  • Moore Capital Management's Teladoc Health position peaked at $2.22M in Q1 2026.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.